Reference
Wolfromm A, et al. Home administration of subcutaneous rituximab is safe and associated with significant cost saving: A single center experience. Blood 130 (Suppl. 1): 4676, Dec 2017. Available from: URL: http://www.bloodjournal.org/content/130/Suppl_1/4676 [abstract] - France
Rights and permissions
About this article
Cite this article
Rituximab. Reactions Weekly 1695, 321 (2018). https://doi.org/10.1007/s40278-018-44148-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44148-y